Fox Run Management’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-16,350
| Closed | -$258K | – | 623 |
|
|
2022
Q4 | $258K | Buy |
16,350
+1,422
| +10% | +$22.4K | 0.1% | 394 |
|
|
2022
Q3 | $235K | Buy |
+14,928
| New | +$235K | 0.09% | 435 |
|
|
2022
Q1 | – | Sell |
-19,368
| Closed | -$282K | – | 479 |
|
|
2021
Q4 | $282K | Buy |
+19,368
| New | +$282K | 0.17% | 248 |
|
|
2018
Q2 | – | Sell |
-10,900
| Closed | -$191K | – | 633 |
|
|
2018
Q1 | $191K | Buy |
+10,900
| New | +$191K | 0.05% | 640 |
|